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Abstract 
Purpose: Since the recent COVID-19 outbreak, there has been an avalanche of research papers applying deep 
learning based image processing to chest radiographs for detection of the disease. To test the performance of the two 
top models for CXR COVID-19 diagnosis on external datasets to assess model generalizability. 
Methods: In this paper, we present our argument regarding the efficiency and applicability of existing deep learning 
models for COVID-19 diagnosis. We provide results from two popular models - COVID-Net and CoroNet evaluated 
on three publicly available datasets and an additional institutional dataset collected from EMORY Hospital between 
January and May 2020, containing patients tested for COVID-19 infection using RT-PCR.  
Results: There is a large false positive rate (FPR) for COVID-Net on both ChexPert (55.3%) and MIMIC-CXR 
(23.4%) dataset. On the EMORY Dataset, COVID-Net has 61.4% sensitivity, 0.54 F1-score and 0.49 precision 
value. The FPR of the CoroNet model is significantly lower across all the datasets as compared to COVID-Net - 
EMORY(9.1%), ChexPert (1.3%), ChestX-ray14 (0.02%), MIMIC-CXR (0.06%). 
Conclusion: The models reported good to excellent performance on their internal datasets, however we observed 
from our testing that their performance dramatically worsened on external data. This is likely from several causes 
including overfitting models due to lack of appropriate control patients and ground truth labels. The fourth 
institutional dataset was labeled using RT-PCR, which could be positive without radiographic findings and vice 
versa. Therefore, a fusion model of both clinical and radiographic data may have better performance and 
generalization. 
Abbreviations 
DL = deep learning, CNN = convolutional neural network, COVID-19 = Coronavirus disease 2019 
Summary 
Existing COVID-19 detection models for chest radiographs demonstrate extremely poor performance on datasets that 
pre-dated the discovery of COVID-19. They also perform poorly on a new institutional dataset that contains confirmed 
COVID-19 cases. 
Key Points • Two existing models for detection of COVID-19 on chest radiographs were tested on three public datasets and 
one institutional dataset. • There is an extremely high rate of false positive detection of COVID-19 (up to 61%) for one model on datasets 
created before COVID-19. • There is a very high false negative rate (94%) for a second model tested on confirmed COVID-19 cases from 
our institution. 
• This may be due to a combination of factors, including overfitting of models on training datasets, similar 
appearance of COVID-19 to other infections, and a portion of serology positive COVID-19 cases that do not 
demonstrate any chest radiograph findings. 
Introduction 
As of May 2020, the number of global confirmed cases of COVID-19 was over 3.5 million spanning 187 territories 
and six continents. The United States reported more than 1 million cases, with more than 80,000 deaths over a span 
of 3 months. Given the lack of adequate testing kits, curative treatment, or availability of a vaccine, mitigation 
strategies were implemented both in hospitals such as rescheduling of elective cases and limiting visitation; and outside 
of hospitals in the form of contact tracing and social distancing in order to ”flatten the curve.” The gold standard for 
SARS-CoV-2 testing is Reverse Transcription Polymerase Chain Reaction (RT-PCR) [1] with a turnaround time of 4 
to 48 hours. Due to the unavailability of rapid testing , both computed tomography (CT) and chest radiographs (CXR) 
have been utilized in lieu of or as a stopgap for laboratory testing. Even though routine screening of patients with 
imaging is not recommended [2, 3, 4], these exams are still frequently obtained as a test for disease in the outpatient 
and emergency department (ED) settings, and therefore there is value in leveraging any technology to expedite review 
or improve the quality of reads for these cases. 
Deep learning (DL) based architectures have been applied to medical imaging with tremendous success, including 
classification and object localization on CXR, with reported expert-level performance for detection of various chest 
pathologies [5, 6]. With respect to COVID-19, much work has been done recently to detect findings of the disease on 
chest radiographs as a means to rapidly screen a high number of patients[7]. However a major gap in this work is that 
the clinical utility of these models has not been tested on large, external datasets. DL models trained on narrow data 
are known to underperform on external data for various reasons including differences in image acquisition protocols[8, 
9], image processing[10], distribution pipelines (e.g., image compression[11]), and overlooked pathology[12]. For AI 
to be clinically useful, models must generalize to unseen data from different populations. Otherwise there is potential 
for models to perpetuate already existing biases in their training datasets, even exacerbating racial disparities already 
seen in COVID-19. 
To assess clinical utility of AI applied to CXRs for COVID-19, we selected two recently developed open-source deep 
learning based COVID-19 detection models - COVID-Net[13] and CoroNet[14], and applied these models to four 
CXR datasets. Three of these datasets were collected before the spread of COVID-19 and the fourth institutional 
dataset was collected between Jan - May, 2020. We present our in-depth analysis using statistical reasoning and 
qualitative assessment by trained radiologists to assess the results of these existing models on external datasets. 
Materials and Methods  
Chest radiograph Datasets 
In this section, we present details of the CXR datasets used in our experiments. Table 1 summarizes the basic 
demographics of the population in the four datasets and the sections below describe the datasets. Ground truth label 
distribution of the datasets are shown as bar charts in Figure 1. 
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Figure 1: Distributions of the ground truth labels in datasets used in the study: (a) Label distribution in ChexPert v1.0 
Dataset; (b) Label distribution in ChestX-ray14 Dataset; (c) Label distribution in MIMIC-CXR Dataset label indicates a CXR 
without positive RT-PCR within 3 days or no positive RT-PCR at any time; (d) Label distribution in EMORY Dataset - A 
positive label indicates a positive RT-PCR within 3 days of the CXR. A negative 
Table 1. Statistical makeup of the datasets including basic demographics information. Missing information is 
documented as `Not Available’.  Other pulmonary disease refers to effusion, pleural thickening, edema etc. 
 
 EMORY 
Dataset 
ChexPert ChestX-
ray14 
MIMIC-
CXR 
Total COVID-19+ Cases 1,786 0 0 0 
Age (mean/std) 55.9/20.0 60.31/18.56 46.13/ 17.01 Not Available 
 Gender   
Male 930 35917 16630 
Not Available Female 753 28822 14175 
Unknown/unreported 103 1 0 
 Race   
Caucasian 328 
Not 
Available Not Available Not Available 
Black 821 
Asian 230 
Other 63 
Unknown 344 
 Comorbidities   
Pneumonia 665 6047 1413 26222 
Other Pulmonary 
diseases 
78 89778 13702 80417 
 
 
Dataset#1: ChexPert v1.0 ChexPert is a large dataset containing 224316 CXRs of 65240 patients acquired from 
October 2002 to July 2017. The data is labeled with 14 different labels. Label distribution is shown in Figure 1a. 
Dataset#2: ChestX-ray14 (previously ChestX-ray8) The ChestX-ray14 dataset includes 108948 frontal-view CXRs of 
32717 unique patients acquired from 1992 to 2015. 14 disease labels were identified from the associated radiology 
reports using text mining. CXRs with ”No Finding” are not included in the 14 labels. In this dataset, an image can 
have multiple labels. Label distribution is shown in Figure 1b. 
Dataset#3: MIMIC-CXR The MIMIC-CXR-JPG v2.0.0 dataset contains 377110 chest radiographs associated with 
227827 CXRs sourced from the Beth Israel Deaconess Medical Center between 2011 - 2016.  
labels extracted from associated free-text radiology reports using natural language processing. Label distribution is 
shown in Figure 1c. 
Dataset#4: EMORY Dataset (Institution names hided for blind review) With the approval of EMORY Institutional 
Review Board, we extracted 4176 CXRs from 1,786 patients treated across four EMORY Healthcare hospitals 
between January - May 2020 and de-identified the scans. For this dataset, we consider an exam as COVID-19 positive 
if real-time reverse transcriptase-polymerase chain reaction (RT-PCR) results were positive within a 3 day window of 
the CXR exam date. A positive label corresponds to the RT-PCR test result, and does not necessarily mean that the 
radiograph has imaging findings of COVID-19. 
Models 
In this section, we summarize two recently published models - COVID-Net [13] and CoroNet [14] used in our 
evaluation and provide details of our experimentation methodology. 
COVID-Net [13] is a convolutional neural network architecture with a long range of connectivity, designed by 
researchers from University of Waterloo, Canada. This network is specifically designed to maximize the sensitivity to 
COVID-19 to limit the number of missed cases. The architecture includes some innovations. First, it is a light-weight 
network with 117,437,315 trainable parameters which follows a residual projection-expansion- projection-extension 
(PEPX) design pattern. In PEPX, a 1×1 convolution projects features into a lower dimension followed by a second 
1×1 convolution that expands the features into a higher dimension. Second, the architecture sparingly leverages long 
range connections which act as central hubs for earlier layers to connect to much later layers in the network. The model 
was trained on the COVIDx dataset which is comprised of a total of 13,975 CXR images from 13,870 patient cases 
Table 1: Statistical makeup of the datasets including basic demographics information. Missing information is 
documented as ‘Not Available. Other pulmonary disease refers to effusion, pleural thickening, edema etc. with 
learning rate=2e-4, number of epochs=22, batch size=64, factor=0.7, and patience=5. The COVIDx dataset [15] is a 
collection of five different open-source datasets - 1) COVID-19 Image Data Collection, 2) COVID-19 Chest X-ray 
Dataset Initiative, 3) ActualMed COVID-19 Chest X-ray Dataset, 4) RSNA Pneumonia Detection Challenge dataset, 
and 5) COVID-19 radiography database. The authors used traditional data augmentation for training: translation, 
rotation, horizontal flip, zoom, and intensity shift. Reported performance was 93% accuracy and 91% sensitivity. 
CoroNet [14] is a two stage deep learning model which was developed by researchers at the University of 
Illinois at Chicago. The first module called a feature extractor uses AutoEncoders to extract the relevant features and 
information from the raw data. The next module performs image classification based on convolution operations on the 
extracted residual features from the feature extractor module. The classification module uses a ResNet-18 architecture 
pretrained on ImageNet. The model was also trained on the COVIDx dataset and the authors used weighted entropy 
loss to address class imbalance. With this two-stage architecture with unsupervised feature extraction, they generated 
a total of 11.8M trainable parameters which is 10 times fewer parameters than COVID-Net. The authors reported 
93.5% overall class average accuracy with 93.63% precision. 
Experimentation methodology 
For inference on our four datasets, both models were executed with their original weights as provided by the authors. 
In the default configuration, COVID-Net is able to predict three different labels, i.e., ‘COVID-19’, ‘Pneumonia’, and 
‘Normal’ whereas CoroNet predicts ‘COVID-19’ and ‘Healthy’. We assume that no COVID-19 cases were present in 
the ChexPert (images acquired from October 2002 to July 2017), ChestX-ray14 (images acquired from 1992 to 2015), 
and MIMIC-CXR (images acquired from 2011 to 2016) datasets since the SARS-CoV-2 virus was discovered in 
December, 2019 [16]. Thus, for these datasets, we considered any case predicted as COVID-19 positive as a false 
positive and considered this false positive rate as a key measurement of model performance. For the EMORY dataset, 
we have ground truth COVID-19 labels based on RT-PCR test results so we are able to calculate both false positive 
and false negative prediction rates. We also provide a confusion matrix to further illustrate the model results as 
compared to the ground truth. 
Lastly, we produced visual explanations for the results of both models on select cases using the Gradient-weighted 
Class Activation Mapping (Grad-CAM) algorithm [17] to understand the reasoning behind the positive COVID-19 
predictions. These images were randomly sampled and shown to two board certified radiologists to understand the 
possible explanation of COVID-19 prediction. 
All work was done on an 8x Quadro RTX 6000 CUDA enabled GPU machine with 512GB RAM. 
Results 
Table 2 presents the performance analysis of the COVID-Net and CoroNet models over the four different datasets. 
There is a large false positive rate (FPR) for COVID-Net on both ChexPert (55.3%) and MIMIC-CXR (23.4%) 
datasets, highlighting the lack of specificity in these models. Interestingly, the FPR was significantly lower for CXR14 
dataset (only 0.05%) which may be explained by the presence of more cases with nodules and masses compared to 
ChexPert and MIMIC-CXR. Moreover, there are fewer cases marked as lung opacity which can be easily mistaken 
for COVID-19 infection (as well as other types of pneumonia (Figure 1). For EMORY dataset, COVID-Net correctly 
predicted 1255 COVID19 cases as positive and resulted 61.4% sensitivity. However, 1296 cases were wrongly 
predicted as positives and the model also missed 789 COVID-19 cases. Thus the COVID-Net model scored only 0.54 
F1-score and 0.49 precision value on EMORY dataset. 
Table 2: Distribution of the predicted labels from the COVID-Net and CoroNet models across all datasets along with 
validation measurements. FN: false negative, FP: false positive 
Model Labels EMORY 
dataset 
ChexPert ChestX-ray14 MIMIC-CXR 
COVID-Net 
COVID-
19 
Pneumonia 
Normal 
2551 
1298 
327 
123610 
90007 
10031 
523 
40638 
70959 
88068 
183583 
105459 
Validation FP-rate:61.1% FN-rate:38.6% FP-rate: 55.3% FP-rate: 0.5% FP-rate: 23.4% 
CoroNet 
COVID-
19 
Healthy 
322 
3854 
2970 
220678 
21 
112099 
2183 
3749279 
Validation FP-rate:9.1% FN-rate:93.7% FP-rate: 1.3% FP-rate: 0.02% FP-rate: 0.06% 
 
 
 (a) COVID-Net prediction on the ChexPert v1.0 Dataset (b) CoroNet prediction on the ChexPert v1.0 Dataset 
  (c) COVID-Net prediction on the ChestX-ray14 Dataset (d) CoroNet prediction on the ChestX-ray14 Dataset 
 
 (e) COVID-Net prediction on the MIMIC-CXR dataset (f) CoroNet prediction on the MIMIC-CXR Dataset 
Figure 2: Distribution of positive COVID-19 predictions from the COVID-Net and CoroNet models as compared to 
ground truth labels from the ChexPert, ChestX-ray14, and MIMIC-CXR datasets. In the ChexPert and ChestX-ray8 
datasets, a majority of FP predictions were in cases with lung opacities, infiltrations, consolidations, and effusions 
which are seen in a variety of infectious processes, including COVID-19. 
 
The FPR of the CoroNet model is significantly lower across all the datasets as compared to COVID-Net - EMORY 
(9.1%), ChexPert (1.3%), ChestX-ray14 (0.02%), MIMIC-CXR (0.06%). Following the similar trend as of 
COVIDNet, only 19 cases are predicted as COVID-19 positive by CoroNet on the ChestX-ray14 dataset. However, 
false negative rate (FNR) on the EMORY patients dataset is extremely high 93.7% since it correctly identified on 129 
COVID19 positive cases and missed 1915 cases. Table 3 presents the confusion matrix for the COVID-Net and 
CoroNet models on the EMORY Dataset, where RT-PCR test results (within 3 days of the radiograph) are considered 
as ground truth labels. This again highlights the high FPR for COVID-Net and a high FNR of CoroNet. 
In order to understand the models’ bias towards positive COVID-19 prediction, we plotted the distribution 
of ‘COVID19’ predicted labels against the ground truth labels of the ChexPert, ChestX-ray14, and MIMIC-CXR 
dataset. As seen from Figure 2, the highest number of false positive predictions by both COVID-Net and CoroNet in 
ChexPert cases contains lung opacity and the second highest is pleural effusion. CoroNet also predicted mostly lung 
opacity cases as COVID-19 positive in the MIMIC-CXR dataset. Interestingly on the same dataset, COVID-Net 
mostly predicted cases with no chest disease as COVID-19 positive. 
Table 3: Confusion matrix demonstrating predictions of the COVID-Net and CoroNet on the EMORY dataset. The 
COVID-19 dataset demonstrates very high false positive and false negative rates, with close to even distributions for 
both predictions. The CoroNet dataset demonstrates a high propensity for negative predictions with a 94% false 
negative rate. 
 COVID-Net CoroNet 
 T Labels 
 R COVID19+ 
 U COVID19- 
 T       
 
 
Table 4: Percentage of images with support devices detected as COVID19+ by COVID-NET 
Dataset COVID19+ Detections in Images with support 
devices 
ChexPert 52.7% 
MIMIC-CXR 21.2% 
 
The Grad-CAM results help to understand the underlying reasons for a high FP rate for COVID-Net and high FN rate 
for CoroNet. Figure 3, 4, and 5, demonstrate that the COVID-Net model mainly focuses on the presence of support 
devices rather than anatomy for predicting positive COVID-19 labels, predisposing it to assign positive labels to ICU 
patients. Table 4 demonstrates the presence % of support devices present positive predictions for the COVID-19 
positive by COVID-Net on all the datasets. Figure 6 presents the GradCAM for false negative EMORY cases (with 
and without support devices) for CoroNet. Even though the CoroNet model does not have an explicit bias towards 
support devices, in most cases the model’s attention is out of focus. 
 
 
Figure 3: GRAD-CAM images of false positive cases detected by the COVID-net model on the EMORY dataset. All 
three of these radiographs contained an endotracheal tube and parenchymal findings which highlights the possible 
bias of the model to these characteristics 
COVID19+ COVID19- COVID19+ COVID19- 
1255 789 129 1915 
1296 836 193 1939 
P R E D I C T E D 
 Discussion 
For AI to be clinically useful, models must generalize to unseen data from different populations which requires 
adequately sized datasets collected from external sites. The COVID-Net and CoroNet models reported good to 
excellent performance (COVID-Net - 93 % accuracy and 91 % sensitivity; CoroNet - 93.5% accuracy and 93.63 % 
precision) on their internal datasets, however we observed from our testing that their performance dramatically 
worsened on external data. The concept of decreased performance for DL models on external datasets is a known issue 
and was previously described in chest radiography[18] [19] in the range of 3.6 – 5.2% performance decrease in 
detecting pneumonia across institutions. This relatively small drop in performance was attributed to differences in 
differences in labeling[19] as well as data distribution between the datasets. However, in our case the performance 
decreased precipitously which indicates a broader underlying issue. 
The prediction of a COVID-19 diagnosis by both models before the spread of SARS-CoV2 (often by many years) 
highlights that these models are highly overfitted to their training and validation datasets. This issue is likely 
multifactorial, but we believe that primary issue is not model architecture, but rather the lack of appropriate control 
patients in these datasets which come mainly from the ICU rather than the general outpatient or emergency department 
population. Therefore the ability of these models to generalize on four broader patient datasets is severely limited, as 
demonstrated in our results. COVID-Net had an alarmingly high false-positive rate (up to 61 %) when tested on CXR 
datasets collected before the spread of virus. CoroNet had a lower false-positive rate (only 1.3 %) but instead failed to 
detect most confirmed COVID-19 cases in the EMORY dataset. We investigated the results of both models as 
compared to ground truth labels to identify the source of errors and found that instead of learning distinctive imaging 
features for COVID-19 diagnosis, the models mainly focused on either co-association of other findings (e.g. lung 
opacity, pleural effusion) or the presence of support devices. The radiographic appearance of COVID-19 is non-
specific, typically described as symmetric, peripheral-predominant nodular and groundglass opacities. However this 
appearance is also seen in many other atypical and opportunistic infections. It is likely that the true cause of errors is 
somewhere in between these two reasons. 
 
 Figure 4: GRAD-CAM images of false positive cases detected by the COVID-net model on the ChexPert dataset 
The presence of support devices can significantly bias models for many reasons: 1) these devices are much more 
visually apparent than infectious pulmonary findings (which is the true abnormality of interest), 2) they are seen in 
predictable anatomic locations, and 3) they are seen in predictable subsets of patients (i.e. ICU patients). If not 
accounted for in the model results, this would represent a significant source of bias as the models may learn a 
correlation between support devices and underlying infection rather than identification of the infection itself. Both the 
ChestX-ray14 and EMORY datasets did not contain annotations to identify the presence of support devices. 
With respect to the high FN rate on the EMORY dataset (39 % for COVID-Net and 94 % for CoroNet), at least some 
of these errors could be attributed to the fact that no imaging findings are present despite a positive RT-PCR results. 
Based on the authors’ clinical experience, there are a subset of patients which test positive for COVID-19 on serology 
but do not have appreciable findings on CXR. We are investigating this further in ongoing work to determine the rate 
of negative CXRs for patients with positive RT-PCR for COVID-19. This is because the ground truth on the EMORY 
dataset is based on RT-PCR results, rather than radiographic findings. Based on the authors’ experience, there are a 
subset of patients with COVID-19 that either do not demonstrate findings on CXR, or demonstrate findings that are 
non-specific. Our results highlight the challenge of utilizing CXR for screening purposes only where RT-PCR is 
unavailable. 
In regards to adequate training data, there is presently a bottleneck of data available for training models to detect 
COVID-19 that can be attributed to the relatively recent onset of the disease, HIPAA constraints for sharing data, and 
limited collaborative effort. The problem of overfitting and poor generalization is not limited to these two models or 
to the diagnosis of COVID-19. Rather, our results highlight a much broader issue in radiology AI where algorithms 
are frequently trained on narrow datasets and their performance suffers on outside data. Diverse selection of training 
data should include multiple sites, disease types, and careful consideration of the population to be evaluated (i.e. ED 
patients vs ICU patients) to maximize the potential for sustained model performance upon deployment. 
 
   
Figure 5: GRAD-CAM images of false positive cases detected by the COVID-net model in the MIMIC-CXR dataset 
Lastly, COVID-19 is not an imaging diagnosis alone, but rather requires incorporation of multiple elements including 
physical exam, laboratory values, comorbidities, and clinical suspicion of disease. In order to build appropriate DL 
models to detect COVID-19, these additional elements should be included. We believe that a fusion model that 
incorporates these data elements from the EHR will offer better performance. Adoption of COVID-Net and CoroNet 
into clinical workflow as is would place a high burden on the radiologist who has to verify all cases due to high positive 
rates, and capture the missing cases in case of high false negative rate. We therefore advocate to develop AI tools that 
work together in partnership with humans to provide better performance. We also provide evidence that reporting 
expert level or better than expert performance does not equate to clinical utility and only perpetuates the hype of AI 
in radiology[20]. 
Limitations 
Our study has several limitations. Firstly, the mechanism of ground labels differ across the four datasets used. We 
overcome this limitation by focusing on the task of COVID-19 diagnosis, which would be absent in the datasets 
published before December, 2019 when the first case was reported. There is debate on the role of imaging for 
COVID19 screening, hence we used the RT-PCR labeling as a proxy for ground truth labels on the EMORY dataset. 
Our second limitation is with regards to the explainability of the model inference using GRAD-CAM for visualization. 
Saliency maps show areas that contribute the highest probability to the model, and have been shown to be inaccurate 
in some cases. Our focus on this paper was not to explore the performance of various CNN interpretability models, 
and this can be an area of future research. 
 
 
 Figure 6: GRAD-CAM images of false negative cases predicted by the CoroNet model COVID-19 in the Emory 
dataset 
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